Literature DB >> 20009116

Glycogenic hepatopathy: a rare cause of elevated serum transaminases in diabetes mellitus.

M van den Brand1, L D Elving, J P H Drenth, J H J M van Krieken.   

Abstract

Glycogenic hepatopathy (GH) is a rare cause of serum transaminase elevations in type 1 diabetes mellitus (DM). We describe a 29-year-old woman with a history of poorly controlled type 1 DM who presented with hepatomegaly and severe transaminase flares. Liver histology confirmed GH, with glycogen accumulation due to severe fluctuations in both glucose and insulin. GH can be regarded as an adult variant of Mauriac's syndrome. Despite severe laboratory abnormalities, it does not cause liver cirrhosis. Treatment consists of improving glycaemic control.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009116

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  18 in total

1.  Glycogenic hepatopathy in a Korean girl with poorly controlled type 1 diabetes mellitus.

Authors:  Hwal Rim Jeong; Young Seok Shim; Young Bae Kim; Hae Sang Lee; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-03-31

Review 2.  Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus?

Authors:  María Teresa Julián; Núria Alonso; Isabel Ojanguren; Eduarda Pizarro; Enric Ballestar; Manel Puig-Domingo
Journal:  World J Diabetes       Date:  2015-03-15

3.  Elevated Lactic Acid During Ketoacidosis: Pathophysiology and Management.

Authors:  Hamda Houssein Ahmed; David De Bels; Rachid Attou; Patrick M Honore; Sebastien Redant
Journal:  J Transl Int Med       Date:  2019-10-12

4.  Protective effects of honey and bee venom against lipopolysaccharide and carbon tetrachloride-induced hepatoxicity and lipid peroxidation in rats.

Authors:  Noha M Meligi; Suzan Alaa Ismail; Nagy S Tawfik
Journal:  Toxicol Res (Camb)       Date:  2020-10-15       Impact factor: 3.524

5.  Drug-Induced Liver Injury in the Setting of Glycogenic Hepatopathy.

Authors:  Valmiki Maharaj; Matthew Fitz; Xianzdong Ding
Journal:  J Gen Intern Med       Date:  2017-02-21       Impact factor: 5.128

Review 6.  Diagnosis of hepatic glycogenosis in poorly controlled type 1 diabetes mellitus.

Authors:  Stefania Giordano; Antonio Martocchia; Lavinia Toussan; Manuela Stefanelli; Francesca Pastore; Antonio Devito; Marcello G Risicato; Luigi Ruco; Paolo Falaschi
Journal:  World J Diabetes       Date:  2014-12-15

7.  GLYCOGENIC HEPATOPATHY: A COMPLICATION OF UNCONTROLLED DIABETES.

Authors:  Medha Satyarengga; Yelena Zubatov; Sylvaine Frances; Gopal Narayanswami; Rodolfo J Galindo
Journal:  AACE Clin Case Rep       Date:  2017

Review 8.  Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes.

Authors:  Iliana Doycheva; Niraj Patel; Michael Peterson; Rohit Loomba
Journal:  J Diabetes Complications       Date:  2013-01-09       Impact factor: 2.852

9.  Glycogen hepatopathy in a 13-year-old male with type 1 diabetes.

Authors:  Khalid S Aljabri; Samia A Bokhari; Sanaa M Fageeh; Abdullah M Alharbi; Mohamad A Abaza
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

10.  Glycogenic hepatopathy in type 1 diabetes: an underrecognized condition.

Authors:  Komal Eram Imtiaz; Catherine Healy; Sadathulla Sharif; Ian Drake; Fehmida Awan; Jonathan Riley; Fiona Karlson
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.